کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4304884 1288518 2006 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Exogenous Pro-Angiogenic Stimuli Cannot Prevent Physiologic Vessel Regression 2
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی عمل جراحی
پیش نمایش صفحه اول مقاله
Exogenous Pro-Angiogenic Stimuli Cannot Prevent Physiologic Vessel Regression 2
چکیده انگلیسی

BackgroundIn healing wounds, rising levels of vascular endothelial growth factor (VEGF) induce a period of robust angiogenesis. The levels of pro-angiogenic factors in the wound begin to decline just before a period of vascular regression, suggesting that these mediators are necessary to sustain vessel density. The purpose of this study was to determine if the maintenance of pro-angiogenic stimuli in the wound would prevent physiological vessel regression.Materials and methodsA standard subcutaneous sponge wound model was modified by the addition of a mini-osmotic pump, allowing manipulation of the wound milieu by the addition of exogenous growth factors. After initial characterization of this model, exogenous VEGF (10 μg/mL), FGF (10 μg/mL), PDGF (10 μg/mL), or VEGF (10 μg/mL) plus FGF (10 μg/mL) were delivered to wounds and blood vessel density analyzed by immunohistochemistry.ResultsVEGF administration resulted in a transient increase in wound vessel density (P < 0.05). None of the pro-angiogenic growth factors (VEGF, FGF, PDGF, VEGF/FGF) were able to prevent vascular regression (P = NS).ConclusionsThese findings suggest that the anti-angiogenic signals that mediate physiological vascular regression in wounds are strongly dominant over pro-angiogenic stimuli during the later phases of wound healing. Clinical manipulation of anti-angiogenic signals in addition to the currently used pro-angiogenic targets may be needed to achieve therapeutic modulation of blood vessel density.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Surgical Research - Volume 135, Issue 2, October 2006, Pages 218–225
نویسندگان
, , , , , ,